Moreover, PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer, suggesting PIK3CA as a prognostic biomarker in breast cancer [29]. The gene discussed is PIK3CA; the disease is breast carcinoma.